Literature DB >> 7451658

Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants.

G J Cianciolo, R Snyderman.   

Abstract

The chemotactic migration of leukocytes is preceded by an alteration in the cells' shape from round to a characteristic polar configuration. We have developed an assay that shows that human monocytes, when exposed to chemoattractant in suspension, assume this polarized shape. The three types of chemo-attractants studied, a chemotactic lymphokine, complement-activated serum, and the N-formylated oligopeptides, all induced polarization in a time, temperature, and dose-dependent fashion. Nonchemotactic agents such as mitogens or phorbol myristate acetate did not induce polarization. At 37 degrees C, polarization was rapid (<1 min) and was inhibitable by cytochalasin B, sodium azide, or low temperature. A series of N-formylated oligopeptides were studied and their activity in inducing polarization correlated closely (r > 0.99) with their chemotactic activity. Of the entire population of circulating monocytes there is a subpopulation of cells that is capable of polarizing in response to chemotactic stimuli. The maximum percentage of monocytes which polarized to any chemotactic factor was approximately 60%. Furthermore, the combination of several chemotactic factors could not increase the percentage of polarized monocytes above the maximum obtained with an optimal dose of any single chemoattractant. The data also demonstrate that high doses of a chemoattractant can induce a state of cross-desensitization in monocytes that blocks the response of the cells to other types of chemotactic factors. These results support the concept that the monocytes that do respond to chemotactic stimuli are capable of responding to any of several attractants.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7451658      PMCID: PMC371572          DOI: 10.1172/JCI110033

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis.

Authors:  R Snyderman; L C Altman; A Frankel; R M Blaese
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

2.  Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.

Authors:  L C Altman; R Snyderman; R M Blaese
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Abnormal monocyte chemotactic response in cancer patients.

Authors:  D A Boetcher; E J Leonard
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

5.  A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.

Authors:  L C Altman; R Snyderman; J J Oppenheim; S E Mergenhagen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

6.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

7.  Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink, and cattle.

Authors:  J I Gallin; J A Klimerman; G A Padgett; S M Wolff
Journal:  Blood       Date:  1975-06       Impact factor: 22.113

8.  A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes.

Authors:  E J Goetzl; K F Austen
Journal:  Immunol Commun       Date:  1972

9.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  36 in total

1.  Dynamics of avian inflammatory response to cross-linked dextran. Changes in avian blood leukocyte populations.

Authors:  K A Golemboski; S E Bloom; R R Dietert
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

2.  Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects.

Authors:  M Tas; J A Leezenberg; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.

Authors:  J W Larrick; J Wang; B M Fendly; D E Chenoweth; S L Kunkel; T Deinhart
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

4.  A hampered chemoattractant-induced cytoskeletal rearrangement in granulocytes of patients with unexplained severe chronic and relapsing infections of the upper and lower airways. In vitro restoration by G-CSF exposure.

Authors:  P M J Kalkman; W J Fokkens; H J de Wit; J P van de Merwe; H Hooijkaas; J M W van Haarst; H C Hoogsteden; H A Drexhage
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion.

Authors:  Lei Shi; Shigeyuki Tsurusaki; Noriko Futa; Tamami Sakamoto; Tomoko Matsuda; Norikazu Nishino; Ryuji Kunitomo; Michio Kawasuji; Kazutaka Tokita; Tetsuro Yamamoto
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

6.  Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.

Authors:  E M van de Plassche-Boers; M Tas; M de Haan-Meulman; M Kleingeld; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

7.  Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.

Authors:  M Nelson; D S Nelson; P B Spradbrow; V K Kuchroo; P A Jennings; G J Cianciolo; R Snyderman
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

8.  Alveolar macrophage dysfunction in malignant lung tumours.

Authors:  E Lemarie; P Carre; M F Legrand; M Lavandier; E Boissinot; M Renoux; G Renoux
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

Review 9.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

10.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Authors:  B D Meade; P D Kind; J B Ewell; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.